hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol. 58 No. 3, 2008.

Kratko priopćenje
https://doi.org/10.2478/v10007-008-0018-z

Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control

KANAKAPURA BASAVAIAH ; Department of Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India
URDIGERE RANGACHAR ANIL KUMAR ; Department of Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India
KALSANG THARPA ; Department of Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India

Puni tekst: engleski, pdf (99 KB) str. 347-356 preuzimanja: 1.002* citiraj
APA 6th Edition
BASAVAIAH, K., KUMAR, U.R.A. i THARPA, K. (2008). Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control. Acta Pharmaceutica, 58 (3), 347-356. https://doi.org/10.2478/v10007-008-0018-z
MLA 8th Edition
BASAVAIAH, KANAKAPURA, et al. "Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control." Acta Pharmaceutica, vol. 58, br. 3, 2008, str. 347-356. https://doi.org/10.2478/v10007-008-0018-z. Citirano 22.02.2019.
Chicago 17th Edition
BASAVAIAH, KANAKAPURA, URDIGERE RANGACHAR ANIL KUMAR i KALSANG THARPA. "Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control." Acta Pharmaceutica 58, br. 3 (2008): 347-356. https://doi.org/10.2478/v10007-008-0018-z
Harvard
BASAVAIAH, K., KUMAR, U.R.A., i THARPA, K. (2008). 'Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control', Acta Pharmaceutica, 58(3), str. 347-356. doi: https://doi.org/10.2478/v10007-008-0018-z
Vancouver
BASAVAIAH K, KUMAR URA, THARPA K. Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control. Acta Pharm. [Internet]. 2008 [pristupljeno 22.02.2019.];58(3):347-356. doi: https://doi.org/10.2478/v10007-008-0018-z
IEEE
K. BASAVAIAH, U.R.A. KUMAR i K. THARPA, "Gradient HPLC analysis of raloxifene hydrochloride and its application to drug quality control", Acta Pharmaceutica, vol.58, br. 3, str. 347-356, 2008. [Online]. doi: https://doi.org/10.2478/v10007-008-0018-z

Sažetak
A rapid, sensitive and selective method for the determination of raloxifene hydrochloride (RLX) in pure drug and in tablets was developed using gradient high performance liquid chromatography (HPLC). The devised method involved separation of RLX on a reversed phase Hypersil ODS column and determination with UV detection at 284 nm. The standard curve was linear (R = 0.999) over the concentration range of 50-600 μg mL1 with a detection limit of 0.04 μg mL1 and a quantification limit of 0.16 μg mL1. Intra-day and inter-day precision and accuracy of the method were established according to the current ICH guidelines. Intra-day RSD values at three QC levels (250, 450 and 550 μg mL1) were 0.20.5% based on the peak area. The intra-day relative error (er) was between 0.2 and 0.5%. The developed method was successfully applied to the determination of RLX in tablets and the results were statistically compared with those obtained by a literature method. Accuracy, evaluated by means of the spike recovery method, was excellent with percent recovery in the range 97.7103.2 with precision in the range 1.62.2%. No interference was observed from the conformulated substances. The method was economical in terms of the time taken and the amount of solvent used.

Ključne riječi
raloxifene hydrochloride; gradient HPLC; pharmaceuticals

Hrčak ID: 25042

URI
https://hrcak.srce.hr/25042

[hrvatski]

Posjeta: 1.337 *